Home » Stocks » Celcuity

Celcuity Inc. (CELC)

Stock Price: $5.60 USD 0.00 (0.00%)
Updated Oct 19, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 57.62M
Revenue (ttm) n/a
Net Income (ttm) -8.24M
Shares Out 10.29M
EPS (ttm) -0.80
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 19, 2020
Last Price $5.60
Previous Close $5.60
Change ($) 0.00
Change (%) 0.00%
Day's Open 5.60
Day's Range 5.60 - 5.80
Day's Volume 9,054
52-Week Range 4.03 - 16.88

More Stats

Market Cap 57.62M
Enterprise Value 42.32M
Earnings Date (est) Nov 17, 2020
Ex-Dividend Date n/a
Shares Outstanding 10.29M
Float 5.05M
EPS (basic) -0.80
EPS (diluted) -0.80
FCF / Share -0.67
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 26,241
Short Ratio 5.37
Short % of Float 0.52%
Beta 0.78
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 3.62
Revenue n/a
Operating Income -8.51M
Net Income -8.24M
Free Cash Flow -6.83M
Net Cash 15.30M
Net Cash / Share 1.49
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -26.51%
ROE -43.09%
ROIC -463.60%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

(141.07% upside)
Current: $5.60
Target: 13.50
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-7.81-7.93-5.95-3.33-2.26
Net Income-7.36-7.48-6.25-3.31-2.26
Shares Outstanding10.2310.127.466.315.84
Earnings Per Share-0.72-0.74-0.84-0.52-0.39
Operating Cash Flow-6.00-6.08-4.95-2.89-1.98
Capital Expenditures-0.38-0.63-0.24-0.04-0.08
Free Cash Flow-6.38-6.70-5.19-2.93-2.06
Cash & Equivalents18.7624.9224.275.915.12
Total Debt0.260.03---
Net Cash / Debt18.5024.8924.275.915.12
Book Value19.3025.3531.395.615.02
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Celcuity Inc.
Country United States
Employees 27
CEO Brian F. Sullivan

Stock Information

Ticker Symbol CELC
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: CELC
IPO Date September 20, 2017


Celcuity, a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the clinical outcomes of cancer patients treated with targeted therapies in the United States. The company's CELx diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. It is developing CELx HSF test to diagnose two new sub-types of HER2-negative breast cancer. The company is also developing CELx MP test to diagnose 12 new potential cancer sub-types in breast, lung, colon, ovarian, kidney, and bladder cancers. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.